IBDEI3B6 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,815,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITIONAL^9^83
 ;;^UTILITY(U,$J,358.4,816,0)
 ;;=EYE/VISION DISORDERS^10^83
 ;;^UTILITY(U,$J,358.4,817,0)
 ;;=FALLS-INITIAL^11^83
 ;;^UTILITY(U,$J,358.4,818,0)
 ;;=GENITOURINARY^15^83
 ;;^UTILITY(U,$J,358.4,819,0)
 ;;=INFECTION^16^83
 ;;^UTILITY(U,$J,358.4,820,0)
 ;;=KIDNEY/RENAL^17^83
 ;;^UTILITY(U,$J,358.4,821,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^19^83
 ;;^UTILITY(U,$J,358.4,822,0)
 ;;=NEUROLOGICAL/CEREBROVASCULAR^20^83
 ;;^UTILITY(U,$J,358.4,823,0)
 ;;=PAIN^21^83
 ;;^UTILITY(U,$J,358.4,824,0)
 ;;=PULMONARY/RESPIRATORY^22^83
 ;;^UTILITY(U,$J,358.4,825,0)
 ;;=SLEEP DISORDERS^23^83
 ;;^UTILITY(U,$J,358.4,826,0)
 ;;=SYMPTOMS/OTHER CONDITIONS^25^83
 ;;^UTILITY(U,$J,358.4,827,0)
 ;;=FALLS-SEQUELA^12^83
 ;;^UTILITY(U,$J,358.4,828,0)
 ;;=FALLS-SUBSEQUENT^13^83
 ;;^UTILITY(U,$J,358.4,829,0)
 ;;=FUNCTION/GAIT/MOBILITY^14^83
 ;;^UTILITY(U,$J,358.4,830,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^83
 ;;^UTILITY(U,$J,358.4,831,0)
 ;;=NEW PATIENT^2^84
 ;;^UTILITY(U,$J,358.4,832,0)
 ;;=ESTABLISHED PATIENT^1^84
 ;;^UTILITY(U,$J,358.4,833,0)
 ;;=CONSULTATIONS^3^84
 ;;^UTILITY(U,$J,358.4,834,0)
 ;;=ESOPHAGUS^4^85
 ;;^UTILITY(U,$J,358.4,835,0)
 ;;=COLON^3^85
 ;;^UTILITY(U,$J,358.4,836,0)
 ;;=LIVER^6^85
 ;;^UTILITY(U,$J,358.4,837,0)
 ;;=PANCREAS^8^85
 ;;^UTILITY(U,$J,358.4,838,0)
 ;;=SMALL INTESTINE^11^85
 ;;^UTILITY(U,$J,358.4,839,0)
 ;;=STOMACH^12^85
 ;;^UTILITY(U,$J,358.4,840,0)
 ;;=POST SURGERY STATES^9^85
 ;;^UTILITY(U,$J,358.4,841,0)
 ;;=SYMPTOMS^14^85
 ;;^UTILITY(U,$J,358.4,842,0)
 ;;=SCREENING^10^85
 ;;^UTILITY(U,$J,358.4,843,0)
 ;;=BILIARY^2^85
 ;;^UTILITY(U,$J,358.4,844,0)
 ;;=COMOBIDITIES^15^85
 ;;^UTILITY(U,$J,358.4,845,0)
 ;;=ANORECTAL^1^85
 ;;^UTILITY(U,$J,358.4,846,0)
 ;;=INFLAMMATORY BOWEL DISEASE^5^85
 ;;^UTILITY(U,$J,358.4,847,0)
 ;;=OTHER^7^85
 ;;^UTILITY(U,$J,358.4,848,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^13^85
 ;;^UTILITY(U,$J,358.4,849,0)
 ;;=EGD^3^86
 ;;^UTILITY(U,$J,358.4,850,0)
 ;;=SMALL INTESTINE ENDOSCOPY^13^86
 ;;^UTILITY(U,$J,358.4,851,0)
 ;;=SIGMOIDOSCOPY^12^86
 ;;^UTILITY(U,$J,358.4,852,0)
 ;;=COLONOSCOPY^2^86
 ;;^UTILITY(U,$J,358.4,853,0)
 ;;=ERCP^4^86
 ;;^UTILITY(U,$J,358.4,854,0)
 ;;=G-TUBE^6^86
 ;;^UTILITY(U,$J,358.4,855,0)
 ;;=MISCELLANEOUS^9^86
 ;;^UTILITY(U,$J,358.4,856,0)
 ;;=IMMUNIZATION^7^86
 ;;^UTILITY(U,$J,358.4,857,0)
 ;;=MOTILITY^11^86
 ;;^UTILITY(U,$J,358.4,858,0)
 ;;=EUS^5^86
 ;;^UTILITY(U,$J,358.4,859,0)
 ;;=LIVER^8^86
 ;;^UTILITY(U,$J,358.4,860,0)
 ;;=MODERATE SEDATION^10^86
 ;;^UTILITY(U,$J,358.4,861,0)
 ;;=MOST COMMONLY USED^1^86
 ;;^UTILITY(U,$J,358.4,862,0)
 ;;=NEW PATIENT HOME VISIT^2^87
 ;;^UTILITY(U,$J,358.4,863,0)
 ;;=ESTAB PATIENT HOME VISIT^1^87
 ;;^UTILITY(U,$J,358.4,864,0)
 ;;=PC COMMON DIAGNOSES^1^88
 ;;^UTILITY(U,$J,358.4,865,0)
 ;;=ADMINISTRATIVE TOPICS^15^88
 ;;^UTILITY(U,$J,358.4,866,0)
 ;;=ANGINA^16^88
 ;;^UTILITY(U,$J,358.4,867,0)
 ;;=ATHEROSCLEROSIS^17^88
 ;;^UTILITY(U,$J,358.4,868,0)
 ;;=CARDIOVASCULAR^18^88
 ;;^UTILITY(U,$J,358.4,869,0)
 ;;=DERMATOLOGY^22^88
 ;;^UTILITY(U,$J,358.4,870,0)
 ;;=EAR DISORDERS^24^88
 ;;^UTILITY(U,$J,358.4,871,0)
 ;;=EENT^25^88
 ;;^UTILITY(U,$J,358.4,872,0)
 ;;=ENDOCRINE/METABOLIC^26^88
 ;;^UTILITY(U,$J,358.4,873,0)
 ;;=EYE DISORDERS^27^88
 ;;^UTILITY(U,$J,358.4,874,0)
 ;;=EYE INJURY^28^88
 ;;^UTILITY(U,$J,358.4,875,0)
 ;;=GASTROENTEROLOGY^29^88
 ;;^UTILITY(U,$J,358.4,876,0)
 ;;=GU/RENAL^30^88
